Delivery Order SPE2DB22D9239-SPE2DB25FDK79
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,569.85 on August 18, 2025, for the supply of Botox 100 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which is valued at $499,999,999 and remains...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, effective August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on July 22, 2025, for the supply of Botox 100 Unit Vials. The contract utilizes a firm fixed-price delivery model with an ultimate completion date of August 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,850.28 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Botox 100-unit vials. The contract, which carries no set-aside designation, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's Park Ridge, Illinois facility. This delivery order is issued...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDK79Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 through November 2026, which provides the agency with the ability to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems. The company has demonstrated consistent success in securing contracts with the DLA to supply specialized pharmaceutical products ranging from oncology treatments to injectable medications, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets. This particular delivery order for BOTOX represents a routine pharmaceutical supply requirement for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 7/29/25 |